Director Declaration
8 June 2018 07:00 BST Director Declaration AstraZeneca PLC (the Company) today announced that Philip Broadley, a Non-Executive Director of the Company, was appointed as a director of Stallergenes Greer plc following the conclusion of its Annual General Meeting of Shareholders with effect from 7 June 2018. This announcement is made pursuant to Listing Rule 9.6.14 R (2). About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of